Undervalued Stocks w/ $1+ Multiple Potential: IPA.
Post# of 49
https://topnewsguide.com/2022/06/24/undervalu...bjat-sfet/
Immunoprecise Antibodies Ltd (CVE:IPA) (NASDAQ:IPA) – Last but certainly not least, it is IPA that may be looked into a bit more interest by investors at this point in time. There has been no news about the company for quite some time but back on May 9, the company had made a major announcement with regards to its Belgian multi-omics analysis platform provider subsidiary Biostrand.
It was announced that Biostrand had won a grant to the tune of as much as 460,000 Euros from the research fund of the local Flemish government in Belgium named VLAIO.